Sign inGet started

MOEBIUS HANS

Insider CIK 1822494 · ATHA Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ATHA Athira Pharma, Inc. A Award2024-01-042024-01-0810,000— $091,482SEC↗
ATHA Athira Pharma, Inc. M Exercise deriv2023-06-022023-06-067,882— $00SEC↗
ATHA Athira Pharma, Inc. M Exercise2023-06-022023-06-067,882$1.35 $10.6K81,482SEC↗
ATHA Athira Pharma, Inc. A Award2023-05-182023-06-067,764$2.41 $18.7K73,600SEC↗
ATHA Athira Pharma, Inc. A Award deriv2023-01-192023-01-23200,000— $0200,000SEC↗
ATHA Athira Pharma, Inc. P Buy2022-11-152022-11-175,000$3.29 $16.4K65,836SEC↗
ATHA Athira Pharma, Inc. M Exercise deriv2022-10-132022-10-177,881— $07,882SEC↗
ATHA Athira Pharma, Inc. M Exercise2022-10-132022-10-177,881$1.35 $10.6K60,836SEC↗
ATHA Athira Pharma, Inc. P Buy2022-06-282022-06-3010,000$2.88 $28.8K52,955SEC↗
ATHA Athira Pharma, Inc. A Award2022-06-222022-06-2410,000— $042,955SEC↗
ATHA Athira Pharma, Inc. A Award2022-05-182022-06-241,699$7.06 $12.0K32,955SEC↗
ATHA Athira Pharma, Inc. A Award deriv2022-01-182022-01-20180,000— $0180,000SEC↗
ATHA Athira Pharma, Inc. A Award2021-11-182022-01-20829$12.51 $10.4K31,256SEC↗
ATHA Athira Pharma, Inc. M Exercise deriv2021-07-212021-07-2112,610— $00SEC↗
ATHA Athira Pharma, Inc. M Exercise deriv2021-07-212021-07-2115,762— $015,763SEC↗
ATHA Athira Pharma, Inc. M Exercise2021-07-212021-07-2115,762$1.35 $21.3K30,427SEC↗
ATHA Athira Pharma, Inc. M Exercise2021-07-212021-07-2112,610$1.35 $17.0K14,665SEC↗
ATHA Athira Pharma, Inc. A Award2021-05-182021-07-212,055$14.45 $29.7K2,055SEC↗
ATHA Athira Pharma, Inc. A Award deriv2021-02-182021-02-2272,000— $072,000SEC↗